64798-35-2Relevant articles and documents
BENZAMIDE COMPOUNDS AS ROR GAMMA MODULATORS
-
Page/Page column 29, (2017/12/16)
The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, R1, R2, R3, R4, R5, n and p are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (RORγt). These compounds prevent, inhibit, or suppress the action of RORγt and are therefore useful in the treatment of RORγt mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, psoriasis, neurodegenerative diseases and cancer.
NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF
-
Page/Page column 143, (2008/12/06)
Compounds of Formula (I) and Formula (II) are useful as inhibitors of HIF prolyl hydroxylases. Compounds of Formula(I) and Formula (II) have the following structures, where the definitions of the variables are provided herein.
3-(α,α-Dimethylbenzyl)urea compounds, compositions, and their use as herbicides
-
, (2008/06/13)
A compound of the general formula (I): STR1 wherein X is halogen or trifluoromethyl, n and m are 0 or 1, R1 is lower C1 - C2 alkyl or C1 - C2 alkoxy and R2 is C4 - C5